Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
OBIO
#3294
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.1
9
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.57%
Monthly Change
+35.51%
6 month change
+22.12%
Year Change
+92.22%
Previous Close
5.1
1
Open
5.1
9
Low
5.1
9
High
5.1
9
Volume
19
Markets
US Stock Market
Healthcare
Biotechnology
OBIO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
20.45 M
20.45 M
11.21 M
35.78 M
38.31 M
58.52 M
60.11 M
Valuation ratios
Enterprise value
—
—
—
283.57 M
145.28 M
222.44 M
321.5 M
Price to earnings ratio
—
—
—
-5.93
-2.41
-3.74
-6.16
Price to sales ratio
—
—
—
105.69
55.83
5.92
7.66
Price to cash flow ratio
—
—
—
6.32
2.91
-4.05
-5.2
Price to book ratio
—
—
—
0.52
0.23
3.7
1.75
Enterprise value to EBITDA ratio
—
—
—
-5.54
-2.27
-4.32
-5.58
Profitability ratios
Return on assets %
—
-0
-0.04
-0.52
-0.8
-0.46
-0.21
Return on equity %
—
0.1
0.39
-0.72
-1.85
-0.98
-1.23
Return on invested capital %
—
—
—
-116.1
1 422.02
-2 692.32
—
Gross margin %
—
—
—
93.26
92.27
99.43
71.59
Operating margin %
—
—
—
-1 866.16
-2 437.49
-154.73
-25.4 K
EBITDA margin %
—
—
—
-1 855.76
-2 425.82
-153.75
-25.3 K
Net margin %
—
—
—
-1 779.71
-2 313.27
-157.4
-26.99 K
Liquidity ratios
Quick ratio
—
—
—
7.94
4.26
6.43
8.24
Current ratio
18.07
10.88
0.17
7.95
4.27
6.45
8.26
Inventory turnover
—
—
—
0
0
0
—
Asset turnover
—
—
—
0.03
0.03
0.29
0
Solvency ratios
Debt to assets ratio
—
—
—
—
0.19
0.12
0.3
Debt to equity ratio
—
—
—
—
0.43
0.27
1.8
Long term debt to total assets ratio
—
—
—
—
0.2
0.13
0.3
Long term debt to total equity ratio
—
—
—
—
0.46
0.28
1.8
Per share metrics
Operating cash flow per share
—
—
-0.1
-1.39
-1.37
-1.03
-0.98
EBIT per share
—
—
—
-1.55
-1.75
-1.09
-0.95
EBITDA per share
—
—
—
-1.54
-1.74
-1.08
-0.94
Total debt per share
—
—
—
—
0.39
0.3
0.55
Cash per share
—
—
0.01
2.64
1.81
2.23
1.72
Net current asset value per share
—
—
0.02
2.68
1.88
2.26
1.74
Tangible book value per share
—
—
-0.42
2.05
0.9
1.12
0.3
Working capital per share
—
—
-0.09
2.34
1.44
1.91
1.53
Book value per share
—
—
-0.42
2.05
0.9
1.12
0.3
News
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
NovoCure (NVCR) Reports Q1 Loss, Beats Revenue Estimates
Chardan reiterates Orchestra BioMed stock rating on trial focus
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Orchestra BioMed to present hypertension therapy data at medical meetings
TD Cowen initiates Orchestra BioMed stock with Buy rating on novel medical device portfolio
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates